A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer

NCT03258034 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: SPA

Sponsor

The First Affiliated Hospital of Zhejiang Chinese Medical University

Collaborators

[object Object]
[object Object]